PE Ratio: 55.53

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/E ratio high or low?

The P/E ratio of 55.53 is 264% above its 1-year average of 15.24, near the high end of its 1-year range (0.21–55.53).

As of 2026-10-06T11:36:18.884Z. 166.07% above its 12-month average of 20.87.

PE Ratio (55.53) = Close Price ($10.90) / Diluted TTM EPS ($0.20)

DMAA PE Ratio Metrics

P/E vs. its own history

At 55.5, P/E is above its 1-year median — higher than 100% of readings in its 1-year history.

P/E Comparison

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)?

The P/E ratio for DMAA stock is 55.53.

Is Drugs Made In America Acquisition Corp. Ordinary Shares's P/E ratio high or low?

The P/E ratio of 55.53 is 264% above its 1-year average of 15.24, near the high end of its 1-year range (0.21–55.53).

What is the TTM average P/E ratio for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)?

The TTM average P/E ratio for DMAA stock is 20.87.

Showing the most recent 260 of 345 data points. The chart above shows the full history.

Related Metrics